feed,title,long_url,short_url
Benzinga,"EyePoint Pharma Posts Deeper Losses For Q4, Expects Cash Runway Into 2024",https://benzinga.com/general/biotech/23/03/31160136/eyepoint-pharma-posts-deeper-losses-for-q4-expects-cash-runway-into-2024,https://da.gd/R2ODt
Benzinga,EXCLUSIVE: BioRestorative To Receive Third US Patent For Metabolic ThermoStem Program,https://benzinga.com/news/23/03/31159370/exclusive-biorestorative-to-receive-third-us-patent-for-metabolic-thermostem-program,https://da.gd/KLcyo
